Thomas E. Sepe

4.0k citations
23 papers · 2.9k · 3 hit papers · h-index 12

Impact in

  • Hepatology top 0.5%
    • Hepatitis C virus research
    • Liver Diseases and Immunity
    • Liver Disease and Transplantation
    • Liver physiology and pathology
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

Thomas E. Sepe

23 papers receiving 2.8k citations

Thomas E. Sepe's Hit Papers

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials 2020 · 404 citations
4040+4+8Years since publication2505007501000

Peers

Thomas E. Sepe
Comparison fields: 5 of 86
  • Hepatology 1.3k
  • Epidemiology 1.8k
  • Gastroenterology 161
  • Endocrinology, Diabetes and Metabolism 462
  • Cell Biology 200
Replace Victor Ankoma‐Sey with:
Victor Ankoma‐Sey United States
W Knapple United States
Parvez Mantry United States
Oreste Lo Iacono Spain
Hans Orlent Belgium
Prashant Pandya United States
Mikio Yanase Japan
Saumya Jayakumar Canada
Andrew J. Fowell United Kingdom
Ziv Ben Ari Israel
Thomas E. Sepe relative to Victor Ankoma‐Sey United States Victor Ankoma‐Sey's profile →
Citations per field
00.5×2×3×4×4.8×
Victor Ankoma‐Sey · 1×
Citations per year

Countries citing papers authored by Thomas E. Sepe

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Sepe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Sepe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Sepe more than expected).

Fields of papers citing papers by Thomas E. Sepe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Sepe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Sepe. The network helps show where Thomas E. Sepe may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas E. Sepe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas E. Sepe Line = papers co-authored together Thomas E. Sepe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191063
2
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Hit paper breakdown →
2014588
3
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Hit paper breakdown →
2020404
4 2019293
5 1994145
6 1995120
7 201582
8 201244
9 201826
10 199824
11 201623
12 199618
13 20108
14 20088
15 20236
16 20175
17 20185
18 20164
19 20194
20
Probability of Sustained Virologic Response (SVR) Is Associated With the Magnitude of HCV RNA Reduction at Week 4 of Treatment With Peginterferon (PEG) Plus Ribavirin (RBV): Results of the IDEAL Trial
20082

About Thomas E. Sepe

Thomas E. Sepe is a scholar working on Hepatology, Rheumatology, Gastroenterology, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers), HIV/AIDS drug development and treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers), Gastrointestinal disorders and treatments (2 papers), Hepatitis B Virus Studies (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (1 paper). The work is most often cited by research in Hepatology (1.3k citations), Epidemiology (1.8k citations), Gastroenterology (161 citations), Endocrinology, Diabetes and Metabolism (462 citations) and Cell Biology (200 citations). Thomas E. Sepe has collaborated with scholars based in United States, Germany and France. Frequent co-authors include John R. Saltzman, Robert Mitchell Russell, Marcos C. Pedrosa, B B Golner, Kris V. Kowdley, Gayle Perrone, Richard James Wood, María Pedrosa, Maureen E. O’Brien and Sarah L. Booth. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Journal of the American College of Nutrition, World Journal of Gastroenterology and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact